Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

The FBI has issued a warning about counterfeit versions of compounded weight loss drugs, which have been found to contain ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide ... on about 3,600 customer reviews, it has an A+ rating ...

As a diabetes medication, GLP-1s are able to treat insulin resistance, something that many people with PCOS deal with. “It’s ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...